cgp 52411 has been researched along with Experimental Leukemia in 1 studies
4,5-dianilinophthalimide: structure given in first source
4,5-dianilinophthalimide : Phthalimide substituted at the 4- and 5-positions by anilino groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, M | 1 |
| Kiyoi, H | 1 |
| Yamamoto, Y | 1 |
| Ito, M | 1 |
| Towatari, M | 1 |
| Omura, S | 1 |
| Kitamura, T | 1 |
| Ueda, R | 1 |
| Saito, H | 1 |
| Naoe, T | 1 |
1 other study available for cgp 52411 and Experimental Leukemia
| Article | Year |
|---|---|
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Cell Line, Transformed; Cell Transformation, Neoplast | 2000 |